Structural basis for substrate selection by the SARS-CoV-2 replicase
© 2023. The Author(s), under exclusive licence to Springer Nature Limited..
The SARS-CoV-2 RNA-dependent RNA polymerase coordinates viral RNA synthesis as part of an assembly known as the replication-transcription complex (RTC)1. Accordingly, the RTC is a target for clinically approved antiviral nucleoside analogues, including remdesivir2. Faithful synthesis of viral RNAs by the RTC requires recognition of the correct nucleotide triphosphate (NTP) for incorporation into the nascent RNA. To be effective inhibitors, antiviral nucleoside analogues must compete with the natural NTPs for incorporation. How the SARS-CoV-2 RTC discriminates between the natural NTPs, and how antiviral nucleoside analogues compete, has not been discerned in detail. Here, we use cryogenic-electron microscopy to visualize the RTC bound to each of the natural NTPs in states poised for incorporation. Furthermore, we investigate the RTC with the active metabolite of remdesivir, remdesivir triphosphate (RDV-TP), highlighting the structural basis for the selective incorporation of RDV-TP over its natural counterpart adenosine triphosphate3,4. Our results explain the suite of interactions required for NTP recognition, informing the rational design of antivirals. Our analysis also yields insights into nucleotide recognition by the nsp12 NiRAN (nidovirus RdRp-associated nucleotidyltransferase), an enigmatic catalytic domain essential for viral propagation5. The NiRAN selectively binds guanosine triphosphate, strengthening proposals for the role of this domain in the formation of the 5' RNA cap6.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:614 |
|---|---|
| Enthalten in: |
Nature - 614(2023), 7949 vom: 01. Feb., Seite 781-787 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Malone, Brandon F [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 25.02.2023 Date Revised 14.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41586-022-05664-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352362375 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352362375 | ||
| 003 | DE-627 | ||
| 005 | 20240214232635.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41586-022-05664-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1292.xml |
| 035 | |a (DE-627)NLM352362375 | ||
| 035 | |a (NLM)36725929 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Malone, Brandon F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Structural basis for substrate selection by the SARS-CoV-2 replicase |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.02.2023 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Nature Limited. | ||
| 520 | |a The SARS-CoV-2 RNA-dependent RNA polymerase coordinates viral RNA synthesis as part of an assembly known as the replication-transcription complex (RTC)1. Accordingly, the RTC is a target for clinically approved antiviral nucleoside analogues, including remdesivir2. Faithful synthesis of viral RNAs by the RTC requires recognition of the correct nucleotide triphosphate (NTP) for incorporation into the nascent RNA. To be effective inhibitors, antiviral nucleoside analogues must compete with the natural NTPs for incorporation. How the SARS-CoV-2 RTC discriminates between the natural NTPs, and how antiviral nucleoside analogues compete, has not been discerned in detail. Here, we use cryogenic-electron microscopy to visualize the RTC bound to each of the natural NTPs in states poised for incorporation. Furthermore, we investigate the RTC with the active metabolite of remdesivir, remdesivir triphosphate (RDV-TP), highlighting the structural basis for the selective incorporation of RDV-TP over its natural counterpart adenosine triphosphate3,4. Our results explain the suite of interactions required for NTP recognition, informing the rational design of antivirals. Our analysis also yields insights into nucleotide recognition by the nsp12 NiRAN (nidovirus RdRp-associated nucleotidyltransferase), an enigmatic catalytic domain essential for viral propagation5. The NiRAN selectively binds guanosine triphosphate, strengthening proposals for the role of this domain in the formation of the 5' RNA cap6 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Coronavirus RNA-Dependent RNA Polymerase |2 NLM | |
| 650 | 7 | |a EC 2.7.7.48 |2 NLM | |
| 650 | 7 | |a NSP12 protein, SARS-CoV-2 |2 NLM | |
| 650 | 7 | |a EC 2.7.7.48 |2 NLM | |
| 650 | 7 | |a Nucleosides |2 NLM | |
| 650 | 7 | |a RNA, Viral |2 NLM | |
| 650 | 7 | |a remdesivir |2 NLM | |
| 650 | 7 | |a 3QKI37EEHE |2 NLM | |
| 650 | 7 | |a Guanosine Triphosphate |2 NLM | |
| 650 | 7 | |a 86-01-1 |2 NLM | |
| 650 | 7 | |a RNA Caps |2 NLM | |
| 650 | 7 | |a GS-441524 triphosphate |2 NLM | |
| 650 | 7 | |a AEL0YED4SU |2 NLM | |
| 700 | 1 | |a Perry, Jason K |e verfasserin |4 aut | |
| 700 | 1 | |a Olinares, Paul Dominic B |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Hery W |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, James |e verfasserin |4 aut | |
| 700 | 1 | |a Appleby, Todd C |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Joy Y |e verfasserin |4 aut | |
| 700 | 1 | |a Bilello, John P |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Honkit |e verfasserin |4 aut | |
| 700 | 1 | |a Sotiris, Johanna |e verfasserin |4 aut | |
| 700 | 1 | |a Ebrahim, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Chua, Eugene Y D |e verfasserin |4 aut | |
| 700 | 1 | |a Mendez, Joshua H |e verfasserin |4 aut | |
| 700 | 1 | |a Eng, Ed T |e verfasserin |4 aut | |
| 700 | 1 | |a Landick, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Götte, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Chait, Brian T |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Elizabeth A |e verfasserin |4 aut | |
| 700 | 1 | |a Darst, Seth A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature |d 1945 |g 614(2023), 7949 vom: 01. Feb., Seite 781-787 |w (DE-627)NLM000008257 |x 1476-4687 |7 nnns |
| 773 | 1 | 8 | |g volume:614 |g year:2023 |g number:7949 |g day:01 |g month:02 |g pages:781-787 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41586-022-05664-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 614 |j 2023 |e 7949 |b 01 |c 02 |h 781-787 | ||